Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

A new tool for detection of type I interferon activation in systemic lupus erythematosus.

Kirou KA, Kalliolias GD.

Arthritis Res Ther. 2010;12(4):138. doi: 10.1186/ar3114. Epub 2010 Aug 26.

PMID:
20815919
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.

Li Y, Lee PY, Kellner ES, Paulus M, Switanek J, Xu Y, Zhuang H, Sobel ES, Segal MS, Satoh M, Reeves WH.

Arthritis Res Ther. 2010;12(3):R90. doi: 10.1186/ar3017. Epub 2010 May 18.

PMID:
20478071
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Type I IFN system in the development and manifestations of SLE.

Elkon KB, Wiedeman A.

Curr Opin Rheumatol. 2012 Sep;24(5):499-505. doi: 10.1097/BOR.0b013e3283562c3e. Review.

PMID:
22832823
[PubMed - indexed for MEDLINE]
4.

Type I interferon and systemic lupus erythematosus.

Elkon KB, Stone VV.

J Interferon Cytokine Res. 2011 Nov;31(11):803-12. doi: 10.1089/jir.2011.0045. Epub 2011 Aug 22. Review.

PMID:
21859344
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Detection of anti-interferon antibodies in systemic lupus erythematosus.

Suit BE, Axelrod D, Moutsopoulos HM, Decker JL, Hooks JJ.

Clin Exp Rheumatol. 1983 Apr-Jun;1(2):133-5.

PMID:
6442634
[PubMed - indexed for MEDLINE]
6.

A compass that points to lupus: genetic studies on type I interferon pathway.

Kyogoku C, Tsuchiya N.

Genes Immun. 2007 Sep;8(6):445-55. Epub 2007 Jun 21. Review.

PMID:
17581625
[PubMed - indexed for MEDLINE]
7.

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.

Higgs BW, Liu Z, White B, Zhu W, White WI, Morehouse C, Brohawn P, Kiener PA, Richman L, Fiorentino D, Greenberg SA, Jallal B, Yao Y.

Ann Rheum Dis. 2011 Nov;70(11):2029-36. doi: 10.1136/ard.2011.150326. Epub 2011 Jul 28.

PMID:
21803750
[PubMed - indexed for MEDLINE]
8.

The emerging role of interferon in human systemic lupus erythematosus.

Baechler EC, Gregersen PK, Behrens TW.

Curr Opin Immunol. 2004 Dec;16(6):801-7. Review.

PMID:
15511676
[PubMed - indexed for MEDLINE]
9.

Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.

Wenzel J, Zahn S, Bieber T, Tüting T.

Arch Dermatol Res. 2009 Jan;301(1):83-6. doi: 10.1007/s00403-008-0892-8. Epub 2008 Sep 11. Review.

PMID:
18784932
[PubMed - indexed for MEDLINE]
10.

Type I interferon in systemic lupus erythematosus.

Crow MK.

Curr Top Microbiol Immunol. 2007;316:359-86. Review.

PMID:
17969456
[PubMed - indexed for MEDLINE]
11.

Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus.

Mangini AJ, Lafyatis R, Van Seventer JM.

Ann N Y Acad Sci. 2007 Jun;1108:11-23. Review.

PMID:
17893966
[PubMed - indexed for MEDLINE]
12.

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus.

Bauer JW, Baechler EC, Petri M, Batliwalla FM, Crawford D, Ortmann WA, Espe KJ, Li W, Patel DD, Gregersen PK, Behrens TW.

PLoS Med. 2006 Dec;3(12):e491.

PMID:
17177599
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.

Sibbitt WL Jr, Gibbs DL, Kenny C, Bankhurst AD, Searles RP, Ley KD.

Arthritis Rheum. 1985 Jun;28(6):624-9.

PMID:
2408630
[PubMed - indexed for MEDLINE]
14.

Biomarkers for systemic lupus erythematosus: a review and perspective.

Liu CC, Manzi S, Ahearn JM.

Curr Opin Rheumatol. 2005 Sep;17(5):543-9. Review.

PMID:
16093831
[PubMed - indexed for MEDLINE]
15.

MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H, de Vries N, Tak PP, Chen S, Shen N.

Arthritis Rheum. 2009 Apr;60(4):1065-75. doi: 10.1002/art.24436.

PMID:
19333922
[PubMed - indexed for MEDLINE]
Free Article
16.

Systemic lupus erythematosus: all roads lead to type I interferons.

Pascual V, Farkas L, Banchereau J.

Curr Opin Immunol. 2006 Dec;18(6):676-82. Epub 2006 Oct 2. Review.

PMID:
17011763
[PubMed - indexed for MEDLINE]
17.

Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.

Blomberg S, Eloranta ML, Magnusson M, Alm GV, Rönnblom L.

Arthritis Rheum. 2003 Sep;48(9):2524-32.

PMID:
13130472
[PubMed - indexed for MEDLINE]
Free Article
18.

Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.

Liu CC, Manzi S, Kao AH, Navratil JS, Ruffing MJ, Ahearn JM.

Arthritis Rheum. 2005 Oct;52(10):3087-99.

PMID:
16200588
[PubMed - indexed for MEDLINE]
Free Article
19.

Type I interferon correlates with serological and clinical manifestations of SLE.

Dall'era MC, Cardarelli PM, Preston BT, Witte A, Davis JC Jr.

Ann Rheum Dis. 2005 Dec;64(12):1692-7. Epub 2005 Apr 20.

PMID:
15843451
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.

Chiche L, Jourde-Chiche N, Whalen E, Presnell S, Gersuk V, Dang K, Anguiano E, Quinn C, Burtey S, Berland Y, Kaplanski G, Harle JR, Pascual V, Chaussabel D.

Arthritis Rheumatol. 2014 Jun;66(6):1583-95. doi: 10.1002/art.38628.

PMID:
24644022
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk